Medpace

Ergomed appoints Dr Dan Weng as CEO

Friday, June 23, 2017

Ergomed, a company dedicated to the provision of specialized services to the pharmaceutical industry and the development of new drugs, announced the strengthening of its executive team with the appointment of Dr. Dan Weng as its new chief executive officer and a board director of Ergomed. Dr. Weng joins Ergomed with effect from 1 July 2017 from EPS Holdings (EPSHD), a global CRO listed on the Tokyo Stock Exchange.

[Read More]

Medpace expands in the U.K.

Friday, August 14, 2015

Global CRO Medpace has relocated its existing U.K. office in Stirling, Scotland. The new office is roughly three times the size of the former facility, allowing for significant growth in data management, biostatistics, quality assurance, regulatory affairs, clinical operations and safety.

[Read More]

PSI, INC Research, Chiltern best with sites

Wednesday, April 1, 2015

Contract research organizations (CROs) have become more effective in managing working relationships with investigative sites during the past two years, according to a new CenterWatch survey, yet the average CRO continues to fall below performance expectations in many of the areas investigators consider most critical for study success.

[Read More]